Gene · 10491
Papers1,478
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,478
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Respiratory syncytial virus disease morbidity in Australian infants aged 0 to 6 months: a systematic review with narrative synthesis. | BMC Public Health | 2023 | 38129854 | PubTator, text mining | PubMed |
| The extent and quality of qualitative evidence included in health technology assessments: a review of submissions to NICE and CADTH. | Int J Technol Assess Health Care | 2023 | 38126273 | PubTator, text mining | PubMed |
| A review focusing on the role of pyroptosis in prostate cancer. | Medicine (Baltimore) | 2023 | 38115248 | PubTator, text mining | PubMed |
| Data-independent acquisition (DIA) mass spectrometry reveals related proteins involved in the occurrence of early intestinal-type gastric cancer. | Med Oncol | 2023 | 38114688 | PubTator, text mining | PubMed |
| The centrosomal protein 131 participates in the regulation of mitochondrial apoptosis. | Commun Biol | 2023 | 38102401 | PubTator, text mining | PubMed |
| An FGFR2 mutation as the potential cause of a new phenotype including early-onset osteoporosis and bone fractures: a case report. | BMC Med Genomics | 2023 | 38098042 | PubTator, text mining | PubMed |
| SARS-CoV-2-infected hiPSC-derived cardiomyocytes reveal dynamic changes in the COVID-19 hearts. | Stem Cell Res Ther | 2023 | 38087340 | PubTator, text mining | PubMed |
| Analysis of gene expression profile for identification of novel gene signatures during dengue infection. | Infect Med (Beijing) | 2023 | 38076406 | PubTator, text mining | PubMed |
| Synergistic cytotoxicity of fludarabine, clofarabine, busulfan, vorinostat and olaparib in AML cells. | Front Oncol | 2023 | 38074694 | PubTator, text mining | PubMed |
| SPIN-CGNN: Improved fixed backbone protein design with contact map-based graph construction and contact graph neural network. | PLoS Comput Biol | 2023 | 38060617 | PubTator, text mining | PubMed |
| Case Report: A novel de novo variant of COL1A1 in fetal genetic osteogenesis imperfecta. | Front Endocrinol (Lausanne) | 2023 | 38027129 | PubTator, text mining | PubMed |
| Childhood Trauma and Exposure to Violence Interventions: The Need for Effective and Feasible Evidence-Based Interventions. | Children (Basel) | 2023 | 38002851 | PubTator, text mining | PubMed |
| Protocol of a randomised trial of teriparatide followed by zoledronic acid to reduce fracture risk in adults with osteogenesis imperfecta. | BMJ Open | 2023 | 37993151 | PubTator, text mining | PubMed |
| Role of environmental specificity in CASP results. | BMC Bioinformatics | 2023 | 37950210 | PubTator, text mining | PubMed |
| A model to forecast the two-year variation of subjective wellbeing in the elderly population. | BMC Med Inform Decis Mak | 2023 | 37940954 | PubTator, text mining | PubMed |
| Expanding the genetic and clinical spectrum of osteogenesis imperfecta: identification of novel rare pathogenic variants in type I collagen-encoding genes. | Front Endocrinol (Lausanne) | 2023 | 37929041 | PubTator, text mining | PubMed |
| Analysis of Human microRNA Expression Profiling During Diquat-Induced Renal Proximal Tubular Epithelial Cell Injury. | J Inflamm Res | 2023 | 37927960 | PubTator, text mining | PubMed |
| Impact of AlphaFold on structure prediction of protein complexes: The CASP15-CAPRI experiment. | Proteins | 2023 | 37905971 | PubTator, text mining | PubMed |
| Analysis of miRNAs in Osteogenesis imperfecta Caused by Mutations in COL1A1 and COL1A2: Insights into Molecular Mechanisms and Potential Therapeutic Targets. | Pharmaceuticals (Basel) | 2023 | 37895885 | PubTator, text mining | PubMed |
| Assessment of three-dimensional RNA structure prediction in CASP15. | Proteins | 2023 | 37876231 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10491/papers?page=8